Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-290108
Filing Date
2015-08-13
Accepted
2015-08-13 16:38:28
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d949796d10q.htm 10-Q 398664
2 EX-10.1 d949796dex101.htm EX-10.1 7564
3 EX-31.1 d949796dex311.htm EX-31.1 6764
4 EX-31.2 d949796dex312.htm EX-31.2 6753
5 EX-32.1 d949796dex321.htm EX-32.1 5357
  Complete submission text file 0001193125-15-290108.txt   3459667

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT zsan-20150630.xml EX-101.INS 579802
7 XBRL TAXONOMY EXTENSION SCHEMA zsan-20150630.xsd EX-101.SCH 42109
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zsan-20150630_cal.xml EX-101.CAL 66365
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zsan-20150630_def.xml EX-101.DEF 165114
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20150630_lab.xml EX-101.LAB 391753
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20150630_pre.xml EX-101.PRE 277492
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

EIN.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 151051201
SIC: 2834 Pharmaceutical Preparations